08/14/2025
5:30 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2025
7:04 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2025
6:35 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2025
7:03 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
7:43 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2025
1:22 PM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
1:58 PM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
7:36 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
11:31 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
6:00 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2025
9:24 AM | Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for SLNCF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/25/2025
7:59 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
5:46 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
7:06 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
10:21 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
7:35 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
5:49 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
3:12 PM | MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/20/2025
3:14 PM | MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
5:05 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form DEF 14A | |
05/16/2025
5:07 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form ARS | |
05/15/2025
8:02 PM | Redmile Group, LLC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SCHEDULE 13G/A | |
05/08/2025
9:18 AM | Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SCHEDULE 13D/A | |
05/08/2025
7:10 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:35 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:08 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2025
7:03 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
7:06 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form PRE 14A | |
05/02/2025
9:28 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
6:13 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
5:50 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
8:28 AM | Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SCHEDULE 13D/A | |
04/24/2025
6:16 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
9:35 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2025
1:17 PM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
6:50 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
9:47 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
9:50 AM | Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SCHEDULE 13D/A | |
03/06/2025
10:03 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:20 PM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
3:30 PM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Gold Hit $3,500. Here’s What’s Next… (Ad) Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldman Sachs and JPMorgan forecasting as high as $6,000, now may be the most critical time in a generation to move. Claim Your Copy Before Prices Surge Again |
02/27/2025
3:13 PM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
9:59 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
7:03 PM | Redmile Group, LLC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SCHEDULE 13G | |
02/11/2025
5:41 PM | Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SCHEDULE 13G/A | |
01/02/2025
3:32 PM | HELLUMS RHONDA LYNETTE (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:34 PM | Davidson Michael H. (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:36 PM | Ede-Golightly James (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:38 PM | Ross Iain (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:39 PM | Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
TOOMAN CRAIG A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:43 PM | Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
7:00 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
4:32 PM | Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SCHEDULE 13D/A | |
12/09/2024
7:12 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/18/2024
3:54 PM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
8:44 AM | Deep Track Capital, LP (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
| Form SC 13G/A | |
11/14/2024
8:24 AM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024
4:20 PM | Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
| Form F-3ASR | |
MarketBeat All Access